Facebook
Twitter
LinkedIn
ForwardOn Demand 2016 Friday General Sessions
You can earn up to 15 AMA PRA Category 1 Credit(s)™.
This collection covers general sessions from Friday's program. This includes plenaries, symposia, and workshops. The sessions listed below are included in this package:
- The Use of Biologics in Severe Asthma
- W4 - When Cough, Wheeze or Dyspnea Are Not Asthma
- Diagnosis and Treatment of Primary Immune Deficiency
- W6 - Office Procedures for Allergic Skin Diseases
- Pro/Con: The LEAP Study Results Should Be Applied to Foods Other Than Peanuts
- W3 - Food Challenges in Practice: Safe and Simplified
- W5 - Drug Allergy Options Beyond Avoidance: Where the Allergist Matters
- Leading the Pack: Allergists as Anaphylaxis Experts
- W1 - Insect Allergy Update
Release Date: 12/01/2016
Expiration Date: 11/30/2019
Accreditation
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 15 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Learning Objectives
- Discuss the biologic mechanisms underlying asthma and which are targets for biologic therapy
- Describe the characteristics of patients who would be candidates for the newly approved biologic therapies for asthma
- Discuss the biology of asthma and which new inflammatory mediators are candidates for new biologic therapies
- Identify the clinical characteristics that support asthma as the cause of cough, wheeze, or dyspnea
- Recognize that not all coughs or wheezes are asthma
- Differentiate symptoms common for asthma from other causes of those symptoms
- Discuss the use of hematopoietic cell transplantation for primary immune deficiencies
- Describe the current status of newborn screening for severe combined immune deficiency and its impact on patient care
- Discuss advances in gene therapy to treat combined immune deficiency
- Utilize guideline-based clinical criteria and testing for the accurate diagnosis of patients with HAE
- Review the underlying enzymatic pathways involved in the pathogenesis of HAE
- Describe therapies available for on-demand treatment of an HAE attack and for short- and long-term prophylaxis in selected patients
- Describe the different tests for physical urticarial and the indications for skin biopsy and interpretation of skin biopsy results
- Discuss the indications and interpretation of the standard epicutaneous patch testing and the utility of repeat open application testing
- Demonstrate the application of epicutaneous patch testing
- Recommend early feeding practices for infants at risk for development of food allergy
- Recognize current evidence and knowledge gaps regarding primary prevention of food allergy
- Describe how to perform an oral food challenge
- Review indications for an oral food challenge and reasons for deferment
- Discuss diagnostic tests and management options for patients with reported hypersensitivity to antibiotics, including beta-lactams, macrolides, quinolones and sulfonamides
- Discuss diagnostic tests and management options for patients with reported hypersensitivity to aspirin and NSAIDs
- Discuss diagnostic tests and management options for patients with reported hypersensitivity to chemotherapeutic drugs
- Demonstrate competence in allergen selection and administration in successful cluster and rush immunotherapy regimens
- identify patient indications, immunologic mechanisms, and special considerations related to cluster and rush immunotherapy delivery
- Describe minimum equipment needed in an allergist’s office to manage anaphylactic reactions when they occur
- Consider using a patient-oriented anaphylaxis preparedness questionnaire as an educational tool for patients at risk of anaphylaxis
- Discuss the pros and cons of available anaphylaxis outpatient action plans and describe in general terms the current state of the literature with respect to biphasic reactions in terms of incidence rates and predictors
- Recognize the most common insects that cause reaction in humans, as well as the reactions these insects cause
- Develop an evaluation and treatment plan, as well as evaluate how to work with local emergency departments for aftercare of patients seen
- Review management of insect allergy with emphasis on the What’s New section of the upcoming Insect PP
Available Credit
- 15.00 AMA PRA Category 1 Credit™
- 15.00 Attendance
Please login or create an account to take this course.